MFS
PTCT icon

MSI Financial Services’s PTC Therapeutics PTCT Stock Holding History

MSI Financial Services’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5K Buy
+500
New +$5.25K ﹤0.01% 3155

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

MSI Financial Services's PTCT Position: Q4 2016 in Review

MSI Financial Services opened a new position in PTC Therapeutics (PTCT) in Q4 2016: 500 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #3155 among its holdings.

123 funds tracked by Wall St. Rank hold PTCT as of Q4 2016.

  • MSI Financial Services held 500 shares of PTC Therapeutics worth $5K as of Q4 2016.
  • PTC Therapeutics was a new MSI Financial Services position in Q4 2016.
  • PTC Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3155 holding.
  • 123 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.